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Blood culture (BC) is still the standard for diagnosing bloodstream infections (BSIs),
especially those caused by bacteria and fungi. Infection-complicating sepsis or septic
shock often occurs at BSI onset, making necessary to improve the diagnostic yield of
positive BCs. Among the BC systems currently available, the BACT/ALERT® VIRTUO®
(VIRTUO) system has been developed to shorten time to detection (TTD) of positive
BCs. In this study, we assessed TTD for 330 clinically relevant species including 14
Gram-positive, 14 Gram-negative, and 5 yeast isolates in spiked human blood samples
that were tested in parallel with VIRTUO BACT/ALERT® 3D (BTA3D) and BACTECTM
FX (BACTEC) systems. We inoculated 30 colony-forming unit (CFU) from each
microbial suspension into BACT/ALERT® Plus or BACTECTM Plus (aerobic/anaerobic
or pediatric) BC bottles, and we used two different blood volumes to simulate,
respectively, the BCs collected from adult and pediatric patients. Of 2,610 bottles
tested, 2,600 (99.6%) signaled positive in the three systems. Only the BACTEC system
did not detect Staphylococcus lugdunensis isolates in anaerobic bottles. Among adult
simulated cultures, the median TTD was significantly shorter for aerobic/anaerobic
bottles incubated in VIRTUO (11.6 h and 10.1 h) compared to bottles incubated in
either BTA3D (13.3 and 12.3 h) or BACTEC (13.5 and 12.2 h) system. Among pediatric
simulated cultures, the median TTD was significantly shorter for bottles incubated in
VIRTUO (11.2 h) compared to bottles incubated in either the BTA3D (13.0 h) or BACTEC
(12.5 h) system. Compared to BTA3D and/or BACTEC systems, VIRTUO allowed faster
growth detection for most of the 33 microbial species tested. Notable examples were
Salmonella spp. (7.4 h by VIRTUO vs. 10.1 h and 9.2 h by either BTA3D or BACTEC)
and Streptococcus agalactiae (8.1 h by VIRTUO vs. 10.3 and 9.4 h by either BTA3D
Menchinelli et al. Systems’ Detection in Simulated BCs
or BACTEC). The few notable exceptions included Stenotrophomonas maltophilia and
some Candida species. Together, these findings confirm that VIRTUO has greater
potential of improving the laboratory detection of bacteremia and fungemia than the
progenitor BTA3D or the competitor BACTEC system.
Keywords: blood culture, automated system, microbial species, spiked human blood sample, diagnostic accuracy
INTRODUCTION
Despite recent significant advances in clinical microbiology
diagnostics (Dubourg and Raoult, 2016; Ramanan et al., 2017),
blood culture (BC) is still the gold standard for diagnosing
bloodstream infections (BSIs) (Lamy et al., 2016). These
infections are mainly due to bacteria (Goto and Al-Hasan,
2013), although important causative agents are also fungi.
Thus, BC allows successful diagnosis (Peker et al., 2018) and,
subsequently, initiation of appropriate antimicrobial therapy
(Armstrong et al., 2017) for almost all bacteremia and fungemia
cases (Pien et al., 2010). However, BC turnaround time is at
least 48 h including antimicrobial susceptibility testing, owing to
the need for a subculture of the causative organism (Dubourg
and Raoult, 2016). Patients who are currently, or have recently
been, hospitalized are at risk of acquiring a health care-associated
infection (Boev and Kiss, 2017) and are, then, at increased risk
of BSI (Bell and O’Grady, 2017). Serious patient complications
include sepsis and septic shock (Rhodes et al., 2017), which are
often present at the BSI onset, making essential to increase the
diagnostic yield of positive BCs in these settings (Lamy et al.,
2018). Therefore, delayed or missed identification of the BSI
causing organismmay prolong the time to effective antimicrobial
therapy and, then, influence the clinical outcome in sepsis/septic
shock patients (Kumar et al., 2006; Seymour et al., 2017;
Whiles et al., 2017).
Among today’s automated BC systems, BACTECTM FX
(BACTEC; Becton Dickinson, Sparks, MD, USA), and
BACT/ALERT R©3D (BTA3D; bioMérieux,Marcy l’Étoile, France)
are the most widely used systems in the clinical microbiology
laboratory. Both the systems employ resin-containing media
in BC bottles (i.e., BACTEC FX Plus or BACT/ALERT FAN
Plus) to enhance the organism recovery. While the BTA3D
instrument with its various generations was in use since 1998,
in 2014 bioMérieux developed the BACT/ALERT R©VIRTUOTM
system (VIRTUO).While relying on the same detection principle
as the BTA3D using BACT/ALERT BC bottles, VIRTUO has
several advantages over previous BTA3D generations. These
consist of (i) a new instrument design to improve temperature
stability, (ii) automatic loading and unloading of BC bottles to
reduce manual processes, and, importantly, (iii) an enhanced
proprietary algorithm to shorten time to detection (TTD) of
positive cultures (http://www.biomerieux-diagnostics.com/bact-
alertr-virtuor-0).
In showing comparative results between the VIRTUO and
BTA3D, a large multicenter clinical study by Jacobs et al. (2017)
relates the finding of shorter TTD by VIRTUO to organism
group, with the TTD being significantly shorter (p < 0.001) only
for enteric Gram-negative bacilli and enterococci. Previously, a
study of simulated BCs comparing the VIRTUO and BTA3D
systems by Altun et al. (2016) found that the TTD was shortened
by roughly 20% in the VIRTUO system (p < 0.0001), and
the performance of the BC system was systematically noted
across all organisms tested (r = 0.91; p < 0.001). Thus, while
Altun et al. (2016) did not observe striking differences in TTD
between microbial species, differences between the two systems
in the study by Jacobs et al. (2017) were not seen for all
organism groups. Taken together, these findings suggest that
factors not present in the simulated study (e.g., low bacterial
load) might be responsible for the time difference in organism
recovery by VIRTUO and BTA3D systems in the clinical study.
In their evaluation, Altun et al. (2016) tested horse blood
samples spiked with 115 clinical bacterial and fungal isolates
in BC bottles. In another controlled study, Somily et al. (2018)
obtained simulated cultures using human blood samples spiked
with 17 reference strains of aerobes, anaerobes, and yeast. The
authors found that the TTD by VIRTUO was significantly
shorter in 72.7% of the tested organisms compared to that of
the BACTEC system, calling for further VIRTUO vs. BACTEC
comparisons in vitro.
Therefore, we aimed to assess proper microbial growth,
positive BC bottle detection, and TTD by the VIRTUO
system for clinically relevant bacterial and yeast species
by using spiked human blood samples tested in parallel
with the BTA3D and BACTEC systems. Specifically, we
used blood volumes per aerobic/anaerobic or pediatric
bottle that were different from each other and according
to the manufacturer’s instructions to simulate, respectively,
the BCs collected from adult and pediatric patients in
clinical practice.
We presented part of this study at the 26th European
Congress of Clinical Microbiology and Infectious Diseases,
Amsterdam, The Netherlands 2016. Lab automation, Paper
poster session P0958.
MATERIALS AND METHODS
Study Design and Organisms
We performed a direct comparison of VIRTUO with the BTA3D
and BACTEC systems by parallel testing of clinical isolates (n =
330) in simulated BCs obtained as described below. We chose
isolates of microbial species within 14 Gram-negative (n = 140),
14 Gram-positive (n = 140), and 5 yeast (n = 50) organism
types (Tables 1, 2). Almost all were aerobic organisms. We
originally collected isolates from BCs of patients hospitalized at
the Policlinico Universitario “A. Gemelli” IRCCS in Rome, Italy,
which we identified at the clinical microbiology laboratory from
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TABLE 2 | Time to detection (TTD) in pediatric blood culture (BC) bottles from the VIRTUO, BTA3D, and BACTEC BC systems.
Species isolates (n) TTD (median, h) by
VIRTUO BTA3D BACTEC
VIRTUO vs. BTA3D (p)a VIRTUO vs. BACTEC (p)a
Gram-negative species (130) 10.1 12.0 10.8 < 0.001 < 0.001
Acinetobacter baumannii (10) 10.0 11.2 11.1 0.005 0.005
Citrobacter freundii (10) 11.1 12.4 11.5 0.005 0.005
Enterobacter cloacae (10) 9.5 11.3 10.4 0.005 0.02
Escherichia coli (10) 9.1 11.1 10.7 0.005 0.005
Klebsiella aerogenes (10) 9.5 11.4 10.5 0.005 0.04
Klebsiella oxytoca (10) 9.8 12.1 11.2 0.005 0.005
Klebsiella pneumoniae (10) 9.8 12.1 11.1 0.005 0.009
Morganella morganii (10) 10.1 11.3 9.8 0.005 NS
Proteus mirabilis (10) 11.1 13.0 12.4 0.005 0.005
Pseudomonas aeruginosa (10) 13.5 15.3 15.3 0.005 0.005
Salmonella spp. (10) 7.9 10.2 9.1 0.005 0.005
Serratia marcescens (10) 9.4 11.3 10.1 0.005 0.02
Stenotrophomonas maltophilia (10) 17.2 17.3 15.4 NS 0.005
Gram-positive species (130) 13.5 15.2 16.1 < 0.001 < 0.001
Enterococcus faecalis (10) 8.4 10.3 9.5 0.005 0.005
Enterococcus faecium (10) 9.6 12.2 12.0 0.005 0.005
Listeria monocytogenes (10) 15.3 17.1 16.4 0.005 0.005
Staphylococcus aureus (10) 13.3 15.2 16.1 0.005 0.005
Staphylococcus capitis (10) 14.4 17.5 17.5 0.005 0.005
Staphylococcus epidermidis (10) 14.2 16.2 17.2 0.005 0.005
Staphylococcus haemolyticus (10) 14.2 17.2 18.1 0.005 0.005
Staphylococcus hominis (10) 17.2 18.4 19.0 0.005 0.005
Staphylococcus lugdunensis (10) 13.6 16.3 16.3 0.005 0.005
Streptococcus agalactiae (10) 8.1 10.3 9.4 0.005 0.005
Streptococcus mitis (10) 9.4 12.4 12.2 0.005 0.005
Streptococcus pneumoniae (10) 13.5 14.5 14.4 0.005 0.005
Streptococcus pyogenes (10) 10.1 12.3 11.3 0.005 0.005
Yeast species (50) 25.2 28.8 24.8 < 0.001 NS
Candida albicans (10) 25.2 25.8 24.8 0.005 NS
Candida glabrata (10) 31.1 32.6 31.3 0.009 NS
Candida krusei (10) 18.3 19.5 18.5 0.005 NS
Candida parapsilosis (10) 32.4 33.5 31.5 0.005 0.01
Candida tropicalis (10) 17.4 18.2 18.4 0.005 0.005
Total (310) 11.2 13.0 12.5 < 0.001 < 0.001
aStatistically not significant (NS) p > 0.05.
the same hospital. All isolates were from single patient episodes
of bacteremia or candidemia, and were stored at−80◦C until use.
BC Simulation and Processing
Before inoculating the bottles and spiking with blood, we
cultured all 330 isolates from frozen stocks onto appropriate
solid media (blood agar for bacterial isolates and Sabouraud
dextrose agar for yeast isolates) and we subcultured a single
colony of each isolate to ensure pure growth. We confirmed
the isolate identity by MALDI BioTyper based identification
as previously described (Fiori et al., 2016). We prepared
isolate suspensions in phosphate-buffered saline to reach a final
inoculum concentration of 3 × 102 CFU/ml, and we inoculated
0.1ml of each suspension (equivalent to 30 CFU) into each
BC bottle with human blood derived from refrigerated, banked
healthy donor blood, of which sterility was previously checked
through culture.We used three blood volumes: 0ml, representing
sterile body fluid, 4ml, representing a pediatric blood sample
volume, and 8ml, representing an adult blood sample volume.
Uninoculated bottles containing 0, 4, or 8ml blood served
as negative controls. This allowed simulating a bacteremia or
candidemia level of approximately 3–4 CFU/ml for adult BCs
and 7–8 CFU/ml for pediatric BCs (https://clinmicro.asm.org/
cumitech-31a). BC bottles were BACT/ALERT R© FA Plus, FN
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Plus, and PF Plus in the VIRTUO and BTA3D systems, and
BACTEC
TM
Plus Aerobic/F, Plus Anaerobic/F, and Peds Plus/F
in the BACTEC system. We assessed the growth in aerobic
and/or anaerobic bottles for all organisms except for anaerobe
organisms (B. fragilis and C. perfringens), which we cultured
under anaerobic conditions only, and for non-fermentative
Gram-negative bacilli (A. baumannii, P. aeruginosa, and S.
maltophilia) and Candida species, which we cultured under
aerobic conditions only. Bottles were immediately loaded into
the respective BC instruments and incubated up to 5 days or
until they signaled positive. At the time bottles gave a positive
signal or at the end of their incubation period, we subcultured the
BC medium on blood (for bacteria) or Sabouraud dextrose (for
yeast) agar plates, respectively, to confirm true-positive and true-
negative detection results and to exclude contamination. Despite
not conceptually different from the BC performed ordinarily,
these cultures relied on a priori established preferential growth
conditions as well as on expected positive results, which made
straightforward the interpretation of final culture status.
Data Analysis
We performed statistical analyses using both Intercooled Stata
program version 11 and GraphPad Prism 7. We calculated
the growth detection rate as the percentage of positive BC
bottles detected by any BC system and we compared percentages
between BC systems (VIRTUO vs. either BTA3D or BACTEC)
using Fisher’s exact test. We calculated the TTD from the time
when the BC bottle entered into the BC system to when it
signaled as positive. We compared the TTD between BC systems
(VIRTUO vs. either BTA3D or BACTEC) using the Wilcoxon
matched-pair signed-rank test. We considered differences with
p < 0.05 as statistically significant.
RESULTS
VIRTUO, BTA3D, and BACTEC BC Systems
for Simulated Human Blood Cultures
Overall Performance
We incubated BC bottles containing spiked human blood
samples in parallel in each of the VIRTUO, BTA3D, and BACTEC
BC systems under comparison, using 330 isolates from 33
(14 Gram-negative, 14 Gram-positive, and 5 yeast) microbial
species as inocula. In total, we evaluated 2,610 bottles, of which
there were 1,680 aerobic/anaerobic (690 pairs and 300 single)
and 930 pediatric. Of these, 240 were single aerobic/pediatric
bottles inoculated with species that grew only under aerobic
conditions (3 non-fermentative Gram-negatives and 5 yeasts).
Another 60 were single anaerobic bottles inoculated with species
that grew only under anaerobic conditions (1 Gram-negative
and 1 Gram-positive). Almost all spiked bottles (n = 2,600;
99.6%) signaled positive and all control (not spiked) bottles (n
= 783; 100%) signaled negative in the three systems within
the 5-day incubation period. Specifically, among 30 anaerobic
bottles inoculated with S. lugdunensis isolates, 20 bottles signaled
positive in both VIRTUO and BTA3D systems and 10 bottles
signaled negative in the BACTEC system. Subcultures of the
BC medium from the 10 bottles confirmed the absence of
bacterial growth. Excluding the bottles without growth only
in the BACTEC system, there were indeed no differences in
the growth detection rates from the BC systems for all the
bottles tested.
Figure 1 shows the cumulative percentages of positive bottle
detection in the three BC systems over time, according to three
organism groups. Among Gram-negative organisms, ∼ 83, 55,
and 70% of aerobic or pediatric bottles reached positivity within
12 h when incubated in the VIRTUO, BTA3D, or BACTEC
systems, respectively. For anaerobic bottles, the positivity rate by
the three BC systems distributed almost uniformly across all the
time intervals, with approximately 75 to 85% of cultures detected
within 12 h. Among Gram-positive organisms, 100% of aerobic
bottles reached positivity within 18 h by the VIRTUO system and
within 24 h by both the BTA3D and BACTEC systems, whereas
100% positivity was achieved after 18 h in pediatric bottles and
24 h in anaerobic bottles by all the three BC systems. Among
Candida organisms, only 40% of aerobic or pediatric bottles
reached positivity within 24 h, whereas almost 100% positivity
was achieved within 36 h, in all the VIRTUO, BTA3D, and
BACTEC systems.
Performance for Adult Simulated Cultures
Table 1 shows the TTD of the organisms cultured in aerobic
and anaerobic BC bottles from each microbial detection system.
Overall, the TTD was significantly shorter for aerobic or
anaerobic bottles incubated in VIRTUO (median 11.6 and
10.1 h, respectively) compared to bottles incubated in either
BTA3D (median 13.3 and 12.3 h, respectively; p < 0.001 for all
comparisons) or BACTEC (median 13.5 and 12.2 h, respectively;
p < 0.001 for all comparisons). As for Gram-negative species,
median TTDs by VIRTUO in either aerobic (10.2 h) or anaerobic
(9.3 h) cultures were significantly shorter than with BTA3D (12.0
and 11.3 h, respectively; p < 0.001 for all comparisons) and
BACTEC (11.3 and 11.2 h, p < 0.001 for all comparisons). As
for Gram-positive species, median TTDs by VIRTUO in either
aerobic (13.5 h) or anaerobic (14.0 h) cultures were significantly
shorter than with BTA3D (15.5 and 15.5 h, respectively; p <
0.001 for all comparisons) and BACTEC (15.4 and 17.0, p <
0.001 for all comparisons). The most striking differences in
the median TTD (≥3 h) by BC systems regarded S. capitis
when cultured in aerobic bottles (14.3 h by VIRTUO vs. 17.4 h
by BTA3D) and B. fragilis only cultured in anaerobic bottles
(32.3 h by VIRTUO vs. either 37.5 h by BTA3D or 36.2 h by
BACTEC). There were only few not significant differences in
the median TTD (p > 0.05). This included both K. aerogenes
(10.8 h by VIRTUO vs. 11.2 h by BACTEC) and S. maltophilia
(17.3 h by VIRTUO vs. 17.4 h by BTA3D) in aerobic cultures,
and both L. monocytogenes (16.1 h by VIRTUO vs. 18.7 h by
BACTEC) and S. capitis (21.5 h by VIRTUO vs. 21.8 h by
BACTEC) in anaerobic cultures. In particular, the BACTEC
system outperformed BTA3D for 78.5% (11/14) of Gram-
negative species and 35.7% (5/14) of Gram-positive species. As
for yeast species, there were significant differences in the median
TTD between VIRTUO and BTA3D (25.1 h vs. 26.2 h, p < 0.001)
but not significant between VIRTUO and BACTEC (25.1 h vs.
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FIGURE 1 | Cumulative percentages of growth detection by BC systems in aerobic, anaerobic, or pediatric cultures of Gram-negative, Gram-positive, and yeast
organisms. Human blood volumes spiked with each organism in aerobic/anaerobic (8ml) and pediatric (4ml) BACT/ALERT Plus or BACTEC FX Plus bottles for
simulated adult or pediatric BCs, respectively.
24.6 h, p > 0.05). Differences in the median TTD were not
significant (p > 0.05) only for C. albicans (25.1 h by VIRTUO vs.
24.5 h by BACTEC) and C. parapsilosis (32.1 h by VIRTUO vs.
32.2 h by BACTEC).
Performance for Pediatric Simulated Cultures
Table 2 shows the TTD of the organisms cultured in pediatric
BC bottles from each microbial detection system. Overall, the
median TTD was significantly shorter for bottles incubated in
VIRTUO compared to bottles incubated in either the BTA3D
(11.2 h vs. 13.0 h, p < 0.001) or BACTEC (11.2 h vs. 12.5 h, p <
0.001) system. As for Gram-negative species, the median TTD
for cultures by VIRTUO (10.1 h) was significantly shorter than
for cultures by the BTA3D (12.0 h, p < 0.001) and BACTEC
(10.8 h, p < 0.001) systems. As for Gram-positive species, the
median TTD for cultures by VIRTUO (13.5 h) was significantly
shorter than with the BTA3D (15.2 h, p < 0.001) and BACTEC
(16.1 h, p < 0.001) systems. The most striking differences in
the median TTD (≥3 h) by BC systems regarded S. capitis
(14.4 h by VIRTUO vs. 17.5 h by either BTA3D or BACTEC),
S. epidermidis (14.2 h by VIRTUO vs. 17.2 by BACTEC) and
S. mitis (9.4 h by VIRTUO vs. 12.4 h by BTA3D). The only
two not significant differences in the median TTD (p > 0.05)
concernedM.morganii (10.1 h by VIRTUO vs. 9.8 h by BACTEC)
and S. maltophilia (17.2 h by VIRTUO vs. 17.3 h by BTA3D).
In particular, the BACTEC system outperformed BTA3D for
78.5% (11/14) of Gram-negative species and 50.0% (7/14) of
Gram-positive species. As for yeast species, median TTDs of the
VIRTUO, BTA3D, and BACTEC systems were 25.2 h, 28.8 h, and
24.8 h, with differences being significant between VIRTUO and
BTA3D (reduced by 3.6 h, p < 0.001) but not significant between
VIRTUO and BACTEC (p > 0.05). The only differences in the
median TTD that were not significant (p > 0.05) were for C.
albicans (25.2 h by VIRTUO vs. 24.8 h by BACTEC), C. glabrata
(31.1 h by VIRTUO vs. 31.3 h by BACTEC), and C. krusei (18.3 h
by VIRTUO vs. 18.5 h by BACTEC). Accordingly, significant (p
< 0.05) differences between VIRTUO and BTA3D were seen for
all Candida species.
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DISCUSSION
We simulated adult or pediatric patient BCs to compare the
VIRTUO, BTA3D, and BACTEC automated BC systems for their
capability of detecting microbial growth in the aerobic/anaerobic
or pediatric BC bottles incubated in parallel in the three
systems. While seeing that almost all of the bottles provided
a positive signal in either VIRTUO (870/870, 100%), BTA3D
(870/870, 100%), or BACTEC (860/870, 98.8%), we found that
VIRTUO exhibited significantly reduced TTD compared to its
progenitor, the BTA3D system, or its competitor, the BACTEC
system, overall (Tables 1, 2). The greatest reduction in TTD
(approximately 3 h) was with Gram-positive bacteria from either
anaerobic (14.0 h by VIRTUO vs. 17.0 h by BACTEC, p < 0.001)
or pediatric (13.5 h by VIRTUO vs. 16.1 h by BACTEC, p< 0.001)
bottles. Yeast organisms grown in aerobic or pediatric bottles had
TTDs in BACTEC that were equivalent to those in the VIRTUO
system. This mirrored the TTDs of single Candida species (5
in total), such as C. glabrata (29.0 h by BACTEC vs. 32.1 h by
VIRTUO, p = 0.005) and C. krusei (18.5 h by BACTEC vs. 18.8 h
by VIRTUO, p = 0.04) in aerobic bottles and C. parapsilosis
(31.5 h by BACTEC vs. 32.4 h by VIRTUO, p = 0.005) in
pediatric bottles. Except for S. maltophilia, the VIRTUO system
detected all the bacterial species (14 Gram-negative and 14Gram-
positive in total) more quickly than did the other two systems in
both aerobic/anaerobic and pediatric bottles. One example was
Salmonella spp. (7.4 h by VIRTUO vs. 10.1 h and 9.2 h by either
BTA3D or BACTEC) among Gram-negative species (Table 1) or
S. agalactiae (8.1 h by VIRTUO vs. 10.3 h and 9.4 h by either
BTA3D or BACTEC) among Gram-positive species (Table 2). As
seen for S. maltophilia in aerobic/pediatric bottles (TTD values,
15.4/15.4 h by BACTEC; 17.3/17.4 h by VIRTUO; 17.2/17.3 by
BTA3D), the BACTEC system was superior to BTA3D in that
faster growth detection occurred in 11 (78.5%) of 14 Gram-
negative species in both aerobic/anaerobic and pediatric bottles.
A similar scenario involved the 14 Gram-positive species, of
which five (35.7%) in aerobic/anaerobic bottles and seven (50.0%)
in pediatric bottles were detected earlier by BACTEC.
To the best of our knowledge, this is the first controlled in vitro
comparative evaluation of three BC systems, VIRTUO, BTA3D,
and BACTEC, which represent the current landscape of clinical
microbiology laboratory diagnostic tools (Lamy et al., 2018). Our
findings confirm and extend those from recently published head-
to-head evaluations of VIRTUO and BTA3D systems (Altun
et al., 2016; Totty et al., 2017) or VIRTUO and BACTEC systems
(Park et al., 2017; Somily et al., 2018), that have used “artificial
samples” prepared by spiking different concentrations of distinct
bacterial or fungal species into blood. Unlike Altun et al. (2016),
we and others (Totty et al., 2017; Somily et al., 2018) used healthy
human blood to better simulate the BCs routinely collected from
patients at risk of bacteremia or fungemia. Notably, and in line
with Somily et al. (2018) and Totty et al. (2017), our simulation
also relied on two different volumes of blood in aerobic/anaerobic
or pediatric BC bottles to, respectively modeling the adult
and pediatric cultures. This enabled us to effectively stratifying
the current results according to the adult or pediatric bottle
type, which represents an important parameter for the growth
detection and TTD of microorganisms in BCs (CLSI, 2007). In
addition to the volume of blood cultured, we controlled the initial
microbial load for each test organism that we set at approximately
30 CFU per bottle. In a seeded, limit of detection (LoD) phase
of their study, Totty et al. (2017) showed that VIRTUO and
BTA3D were capable of detecting organisms at almost identical
levels. In a seeded, validation phase of the same study, the
authors compared the TTD between the systems for a panel
of clinically relevant microorganisms inoculated at or near the
LoD. While providing a more stringent evaluation compared to
clinical samples, the study by Totty et al. (2017) reported that
VIRTUO had an overall decrease (mean difference) in TTD of
3.48 h, and that Gram-positive organisms had the greatest TTD
improvement. All organisms had faster or equivalent TTD with
VIRTUO, except for S. maltophilia that, as in our study, generated
slower TTD in BACT/ALERT FA Plus bottles. Similarly, Somily
et al. (2018) reported that the TTD for S. maltophilia using the
BACTEC was shorter in pediatric bottles (p ≤ 0.05) but longer
in aerobic bottles compared to the VIRTUO system. In the same
study (Somily et al., 2018), the TTD for C. albicans (the only
Candida species studied) was shorter with the VIRTUO system in
both aerobic (22.1 h vs. 35.9 h) and pediatric bottles (25.6 vs. 33.9)
than with the BACTEC system (p = 0.025). The two Candida
species studied by Altun et al. (2016) showed marked differences
in TTD, with 24 h for C. albicans and 66 h for C. glabrata (p <
0.0001), in both VIRTUO and BTA3D systems. All this was in
apparent disagreement with our observations.
We acknowledge that various other factors like the source
of infection, the presence of antibiotics, and host inhibitory
substances can influence the TTD. Therefore, the simulated BC
model lacks the potential interfering factors known for clinical
samples, but it allows for the direct comparison of the speed
of growth of each individual microorganism to its TTD by a
given BC system. This would result in a better evaluation of
each BC system’s performance, because it would ensure the
control for all the variables that need monitoring to assess
the sensitivity and specificity at the instrument level (Lamy
et al., 2018). By means of simulated BC model, we ruled out
the excess time to load (i.e., from blood collection to loading
the instrument) as a possible cause of false-negative signals
(i.e., bottles flagged negative despite containing microorganism)
in our study. Meanwhile, we ruled out all possible causes
of false-positive signals (i.e., bottles flagged positive without
growth of microorganisms in culture) such as high levels of
leukocytes and/or over-filled bottles. Otherwise, under-filled or
volume-noncompliant BC bottles (i.e., bottles containing blood
volumes of less than the volume recommended; Baron et al.,
2013) as well as slow-growing microorganisms are among the
possible causes of false-negative diagnosis, that is true BSI but
no bacterium/fungus recovered (Lamy et al., 2016). Although
both BACTEC and VIRTUO indirectly or directly estimate the
volume of blood in each bottle, we conducted our study so
that our time to results in each instrument be only dependent
on the microbial density in blood, which is generally very low
(median 1 CFU/ml) in real-life settings (Lamy et al., 2016).
Not surprisingly, accreditation of BCs’ cultures proceedings
could met the ISO 15189 standards for clinical laboratories by
Frontiers in Microbiology | www.frontiersin.org 7 February 2019 | Volume 10 | Article 221
Menchinelli et al. Systems’ Detection in Simulated BCs
monthly spiking bottles with reference microbial strains, but
this approach may not reflect the routine practice condition
because it recommends use of easy-to-grow strains such as
E. coli (Lamy et al., 2018).
Despite our study’s intrinsic limitations, these findings mirror
those derived from controlled clinical studies (Jacobs et al.,
2017). By analyzing for volume-compliant bottle pairs (i.e., mean
volumes per bottle of 4.8ml (VIRTUO) and 4.8ml (BTA3D)
in the pair), Jacobs et al. (2017) noticed significant differences
between the two instruments in median TTD, with the microbial
growth detection by VIRTUO being approximately 2 h earlier
overall than that by the BTA3D system (15.9 h vs. 17.7 h).
Consistent with our findings, there was no significant difference
for the overall rate of detection by both systems in the volume-
noncompliant bottle group, which included either type of non-
volume-compliant (≤ 10-ml and> 10-ml) bottle, vs. the volume-
compliant bottle group (p = 0.194 and p = 0.202, respectively).
In that study (Jacobs et al., 2017), 1,005 of 5,709 bottle pairs
had a blood volume that exceeded 10ml in at least one bottle
of each bottle pair. Of note, the pathogen recovery rate (7.5%,
75/1,005) in these high-volume pairs was significantly (p =
0.044) different from the rate of compliant (5.7%, 203/3,539) or
noncompliant, ≤ 10ml (5.5%, 64/1,165) bottle pairs. While this
difference was associated with the use of BACT/ALERT FA Plus
and FN Plus bottles, the recovery of Candida species was greater
in bottles inoculated with> 10ml (1.9%, 19/1,005) than in bottles
inoculated with ≤ 10ml (0.2%, 10/4,704) (p < 0.0001; Jacobs
et al., 2017). Here, in line with Somily et al. (2018), we used
BACT/ALERT or BACTEC Plus bottles only, because previous
simulated BC system evaluations (Altun et al., 2016; Totty et al.,
2017) did assess the value of resin-based Plus bottles in improving
organism yield and early detection compared with BACT/ALERT
charcoal-based (FA and FN) or standard (SA and SN) bottles.
Consistent with recent evidence-based recommendations for
sepsis (Rhodes et al., 2017), the volume of each blood draw
should be ≥ 10ml. Accordingly, using a standard (10-ml)
volume of blood in each BC bottle, we previously showed
comparable clinical performances of the BACT/ALERT Plus and
BACTEC Plus aerobic and anaerobic BC bottles (Fiori et al.,
2014). However, a blood volume < 8–10ml (e.g., 5-ml) may
be the reason for the striking difference in TTD observed by
Somily et al. (2018) for Haemophilus influenzae and Neisseria
meningitidis, which was shorter with the BACTEC compared to
the VIRTUO system. The authors stated that a higher volume
of blood could lead to neutralization of the inhibitory effect of
sodium polyanethol sulfonate (SPS) on sensitive organisms, thus
optimizing the recovery of these organisms—the anticoagulant
SPS concentration is higher in BACT/ALERT FA Plus bottles
than in BACTEC Plus aerobic/F bottles. In their study, Totty
et al. (2017) compared the BTA3D and VIRTUO systems
using a panel of compatible BC bottles seeded with tightly
controlled organism inocula. The VIRTUO algorithm detected
100% of Fusobacterium nucleatum in FN Plus bottles and
100% of Aspergillus brasiliensis and Cardiobacterium hominis
in FA Plus bottles, whereas the BTA3D system generated false-
negative results for these same combinations. Unfortunately,
we did not include less frequent but clinically relevant species
(i.e., Streptococcus bovis group species or other alpha-hemolytic
streptococcal species) in our study, as we restricted the list of
evaluable microorganisms to the groups of species commonly
causing BSIs. Accordingly, coagulase-negative staphylococci,
E. coli, Enterobacteriaceae (other than E. coli), S. aureus,
Enterococcus species, viridans group streptococci, P. aeruginosa,
and Candida species were the focus of clinical evaluations of
the VIRTUO system (Congestrì et al., 2017; Jacobs et al., 2017).
In this sense, the simulated BCs proposed by us continue to be
a good surrogate of clinical BCs, particularly when an accurate
assessment of new advanced diagnostics is required (Beyda et al.,
2018). Optimizing BC systems is essential to improve patient care
practices and to promote personalized medicine approaches.
In conclusion, the present findings provide further
evidence concerning the superior ability of the VIRTUO
system in diagnosing adult and pediatric BSIs. Compared
to the other two BC systems (BTA3D and BACTEC)
evaluated in this study, VIRTUO allowed to produce a
faster positive result for most of the 33 microbial species
tested. The few notable exceptions included S. maltophilia and
Candida species in both adult and pediatric BCs. Therefore,
VIRTUO represents a great advance over its predecessor,
the BTA3D, in the laboratory detection of bacteremia
and fungemia.
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